Your browser doesn't support javascript.
loading
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
Friedman, Adam A; Amzallag, Arnaud; Pruteanu-Malinici, Iulian; Baniya, Subash; Cooper, Zachary A; Piris, Adriano; Hargreaves, Leeza; Igras, Vivien; Frederick, Dennie T; Lawrence, Donald P; Haber, Daniel A; Flaherty, Keith T; Wargo, Jennifer A; Ramaswamy, Sridhar; Benes, Cyril H; Fisher, David E.
Afiliação
  • Friedman AA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Amzallag A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Pruteanu-Malinici I; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Baniya S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Cooper ZA; Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Genomic Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Piris A; Division of Dermatopathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Hargreaves L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Igras V; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Frederick DT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Lawrence DP; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Haber DA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
  • Flaherty KT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Wargo JA; Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Genomic Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.
  • Ramaswamy S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Benes CH; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Fisher DE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America; Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
PLoS One ; 10(10): e0140310, 2015.
Article em En | MEDLINE | ID: mdl-26461489
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Receptores do Fator de Crescimento Derivado de Plaquetas / Receptores de Fatores de Crescimento do Endotélio Vascular / Proteínas Proto-Oncogênicas B-raf / Terapia de Alvo Molecular / Melanoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Receptores do Fator de Crescimento Derivado de Plaquetas / Receptores de Fatores de Crescimento do Endotélio Vascular / Proteínas Proto-Oncogênicas B-raf / Terapia de Alvo Molecular / Melanoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article